MassFluidix HC upgrade enhances high-concentration analysis
Refeyn has taken another step to assure mass photometry is a simpler, more efficient bioanalytics tool with the release of a powerful expansion of its consumables portfolio.
Refeyn forms new mass photometry Scientific Advisory Board
Refeyn has established a new Scientific Advisory Board, chaired by Justin Benesch, Professor of Biophysical Chemistry, Oxford University and co-founder of Refeyn. To recognize and help realize the full potential of mass photometry’s unique bioanalytical workflow capabilities, the new board includes external scientific experts in pharmaceutical and biologics discovery, process development and manufacture.
Speeding up gene therapy analytics
Genetic Engineering & Biotechnology News (GEN) published a short article discussing how researchers at the UK Centre for Process Innovation (CPI) found mass photometry to be a helpful analytical technique for companies using adeno-associated viruses (AAV) as viral vectors in gene therapies.
Macro mass photometry for rapid viral vector characterization
An article authored by Laura Pala, one of our Product Marketing Managers, has recently been published by Eurolab magazine and also online at ScientistLive. It provides a useful overview of macro mass photometry and how it can help to speed up viral vector characterization, a key analytical step within the production pipeline for cell and gene therapies (CGT) and vaccines.
New US headquarters opened in Waltham, Massachusetts
Refeyn staff join mass photometry inventor Prof. Philip Kukura in cutting ribbon to Refeyn’s new US customer interaction center in Massachusetts’ Waltham Biotech Hub
User innovation takes center stage at 2024 Mass Photometry Summit
The remarkable evolution of mass photometry was celebrated at the annual mass photometry user summit. From prototype to commercially available instrument used in hundreds of laboratories, this innovative technology was on display at the third annual scientific meeting of this event – dedicated to mass photometry users and hosted by Refeyn. The event took place at Wylie Conference Center on May 22 in Beverly, Massachusetts, a coastal suburb of Boston, USA.
Refeyn appoints new Chief Marketing Officer
Refeyn is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024. Forming part of Refeyn’s executive team, Fiona will bring with her a wealth of experience from over 25 years in the biotechnology sector.
Refeyn strengthens capability with new US Headquarters in Boston area
New US customer interaction center opens in Massachusetts’ Waltham Biotech Hub with 3rd annual Mass Photometry Summit set to highlight latest advances
Expert interview on accelerating AAV development processes
ABL, an Institut Mérieux Company, is a distinguished contract development and manufacturing organization (CDMO) providing GMP viral vectors from early stage to market.
Refeyn’s new KaritroMP quickly analyzes large viral vectors
New macro mass photometer can assess the stability, quality, and purity of adenovirus and lentivirus vectors within just minutes
